Irregular Menses, Amenorrhea, and Infertility Following Synthetic Progestational Agents

M. James Whitelaw
In: JAMA: The Journal of the American Medical Association · 1966 · vol. 195(9) , pp. 780 · doi:10.1001/jama.1966.03100090114032 · PMID:5951886 · W2097162634
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

THE USE OF pure crystalline progesterone which was isolated and prepared for the first time in 1934 was limited mainly in its therapy for the first 13 years to the treatment of habitual and threatened abortion. With the clinical introduction of norethandrolone and norethynodrel in 1956 by Rock'1,2and his co-workers as contraceptive agents, as well as steroids to increase fertility, there was a rapid increase in the pharmacological use of these products and related steroidal compounds with progestational activity so that today they are being used in the treatment of several gynecological disorders including amenorrhea, oligomenorrhea, dysfunctional bleeding, dysmenorrhea, infertility, contraception, endometriosis, and others,3-7as well as in the diagnosis of pregnancy. It has been claimed that there are few side reactions of a serious nature, except for fetal virilization,8persistent edema, and thromboembolic disease.9We are presenting these data due to the fact that during

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrheainfertility

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (14)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK